BCBSA and Civica partner to revolutionize drug affordability
In partnership with Blue Cross and Blue Shield companies, Civica announced it would manufacture and distribute insulin for no more than $30 per vial.
Pioneering health care affordability by shedding light on community impact, current events and other key insights.
In partnership with Blue Cross and Blue Shield companies, Civica announced it would manufacture and distribute insulin for no more than $30 per vial.
Learn more about recent health care news and insights.
Subscribe to stay in the know on health care industry news and insights.